Synthon Pharms patent expiration

1. Amlodipine Besylate patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6828339 SYNTHON PHARMS Amlodipine salt forms and processes for preparing them
Nov, 2022

(1 year, 7 months ago)




Drugs and Companies using AMLODIPINE BESYLATE ingredient

Market Authorisation Date: 27 September, 2007

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING

More Information on Dosage

AMLODIPINE BESYLATE family patents

Family Patents